Bifogade filer
Kurs & Likviditet
Prenumeration
Beskrivning
Land | Finland |
---|---|
Lista | First North Finland |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Herantis Pharma Plc | Press Release | September 04, 2023 at 17:10:00 EEST
Herantis Pharma Plc, Press Release, 4 September 2023 at 17:10 EEST
Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Herantis will participate in the following conferences in September 2023:
Sachs 23rd Annual Biotech in Europe Forum
Dates: September 20th - 21st, 2023
Location: Basel, Switzerland
1:1 meetings and company presentation.
CEO, Antti Vuolanto will participate in a panel discussion at Sachs, September 20th, 17:10 CEST.
Topic: Advances in Approaches to Neurological Disorders
Co-Chaired by:
Jenny Laird, VP, Search & Evaluation Neuroscience, Eli Lilly and Company
Henrik Sindal Jensen, Senior Director, Corporate Business Development & Strategy, H. Lundbeck A/S
ØU Life Science Investor Conference
Dates: September 27th, 2023
Location: Copenhagen, Denmark
CEO, Antti Vuolanto will give a company presentation at 14:05-14:35 CEST.
If you want a 1:1 meeting with Herantis, you can connect with us directly at ir@herantis.com.